Cresilon

Saving Lives

Cresilon was founded in 2010, is headquartered in New York, United States, lists 51–200 employees, and has $63.5M in recorded funding across 2 rounds.

Headquarters
New York, New York
Employees
51–200
Founded
2010
Business Model
B2B
Total Funding
$63.5M
Last Round
$25.0M Extension RoundOct 2022
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds for this company. The full record is or through the API.

About

Cresilon is a Brooklyn-based medical device company developing plant-based hemostatic gel technologies for veterinary and human wound care. Its proprietary products include VETIGEL for veterinary procedures and TRAUMAGEL for controlling moderate to severe external traumatic bleeding in people. Founded to manufacture an adhesive gel that supports natural clotting, Cresilon operates a GMP-certified Brooklyn facility and focuses on improving wound care and advancing medical treatment standards.

Summary

Cresilon is a Biotech company based in New York, United States, founded in 2010. It lists 51–200 employees. It has raised $63.5M in total across 2 rounds, most recently a $25.0M Extension Round in Oct 2022.

Tech & App Stack

11 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundSeries A-4Oct 2022
$25.0M

Sign up to see all 2 events

Funding: Extension Round. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cresilon on Indexed.vc
<a href="https://indexed.vc/companies/cresilon"><img src="https://indexed.vc/api/badge/company/cresilon" alt="Cresilon on Indexed.vc" width="260" height="76" /></a>